Literature DB >> 30524648

Simultaneous Assessment of Cardiac Inflammation and Extracellular Matrix Remodeling after Myocardial Infarction.

Isabel T Ramos1,2, Markus Henningsson1, Maryam Nezafat1, Begoña Lavin1,2, Silvia Lorrio1,2, Pierre Gebhardt1,3, Andrea Protti1, Thomas R Eykyn1, Marcelo E Andia4, Ulrich Flögel5, Alkystis Phinikaridou1,2, Ajay M Shah2, René M Botnar1,6.   

Abstract

Background: Optimal healing of the myocardium following myocardial infarction (MI) requires a suitable degree of inflammation and its timely resolution, together with a well-orchestrated deposition and degradation of extracellular matrix (ECM) proteins. Methods and
Results: MI and SHAM-operated animals were imaged at 3,7,14 and 21 days with 3T magnetic resonance imaging (MRI) using a 19F/1H surface coil. Mice were injected with 19F-perfluorocarbon (PFC) nanoparticles to study inflammatory cell recruitment, and with a gadolinium-based elastin-binding contrast agent (Gd-ESMA) to evaluate elastin content. 19F MRI signal co-localized with infarction areas, as confirmed by late-gadolinium enhancement, and was highest 7days post-MI, correlating with macrophage content (MAC-3 immunohistochemistry) (ρ=0.89,P<0.0001). 19F quantification with in vivo (MRI) and ex vivo nuclear magnetic resonance (NMR) spectroscopy correlated linearly (ρ=0.58,P=0.020). T1 mapping after Gd-ESMA injection showed increased relaxation rate (R1) in the infarcted regions and was significantly higher at 21days compared with 7days post-MI (R1[s-1]:21days=2.8 [IQR,2.69-3.30] vs 7days=2.3 [IQR,2.12-2.5], P<0.05), which agreed with an increased tropoelastin content (ρ=0.89, P<0.0001). The predictive value of each contrast agent for beneficial remodeling was evaluated in a longitudinal proof-of-principle study. Neither R1 nor 19F at day 7 were significant predictors for beneficial remodeling (P=0.68;P=0.062). However, the combination of both measurements (R1<2.34Hz and 0.55≤19F≤1.85) resulted in an odds ratio of 30.0 (CI95%:1.41-638.15;P=0.029) for favorable post-MI remodeling. Conclusions: Multinuclear 1H/19F MRI allows the simultaneous assessment of inflammation and elastin remodeling in a murine MI model. The interplay of these biological processes affects cardiac outcome and may have potential for improved diagnosis and personalized treatment.

Entities:  

Keywords:  Fibrosis; Inflammation; Ischemia; Magnetic Resonance Imaging (MRI); Translational Studies; cardiac biomarkers; extracellular matrix; imaging; macrophage; magnetic resonance imaging; molecular imaging; myocardial remodeling

Mesh:

Substances:

Year:  2018        PMID: 30524648      PMCID: PMC6277008          DOI: 10.1161/CIRCIMAGING.117.007453

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  33 in total

1.  Fibulin-5 is an elastin-binding protein essential for elastic fibre development in vivo.

Authors:  Hiromi Yanagisawa; Elaine C Davis; Barry C Starcher; Takashi Ouchi; Masashi Yanagisawa; James A Richardson; Eric N Olson
Journal:  Nature       Date:  2002-01-10       Impact factor: 49.962

2.  Recovery of ventricular function after myocardial infarction in the reperfusion era: the healing and early afterload reducing therapy study.

Authors:  S D Solomon; R J Glynn; S Greaves; U Ajani; J L Rouleau; F Menapace; J M Arnold; C Hennekens; M A Pfeffer
Journal:  Ann Intern Med       Date:  2001-03-20       Impact factor: 25.391

3.  Overexpression of elastin fragments in infarcted myocardium attenuates scar expansion and heart dysfunction.

Authors:  Tomohiro Mizuno; Donald A G Mickle; Chris G Kiani; Ren-Ke Li
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-01-28       Impact factor: 4.733

4.  Late gadolinium enhancement of acute myocardial infarction in mice at 7T: cine-FLASH versus inversion recovery.

Authors:  Andrea Protti; Alexander Sirker; Ajay M Shah; Rene Botnar
Journal:  J Magn Reson Imaging       Date:  2010-10       Impact factor: 4.813

5.  Noninvasive detection of graft rejection by in vivo (19) F MRI in the early stage.

Authors:  U Flögel; S Su; I Kreideweiss; Z Ding; L Galbarz; J Fu; C Jacoby; O Witzke; J Schrader
Journal:  Am J Transplant       Date:  2011-01-07       Impact factor: 8.086

6.  Targeted imaging of the spatial and temporal variation of matrix metalloproteinase activity in a porcine model of postinfarct remodeling: relationship to myocardial dysfunction.

Authors:  Zakir H Sahul; Rupak Mukherjee; James Song; Jarod McAteer; Robert E Stroud; Donald P Dione; Lawrence Staib; Xenophon Papademetris; Lawrence W Dobrucki; James S Duncan; Francis G Spinale; Albert J Sinusas
Journal:  Circ Cardiovasc Imaging       Date:  2011-04-19       Impact factor: 7.792

7.  In vivo monitoring of inflammation after cardiac and cerebral ischemia by fluorine magnetic resonance imaging.

Authors:  Ulrich Flögel; Zhaoping Ding; Hendrik Hardung; Sebastian Jander; Gaby Reichmann; Christoph Jacoby; Rolf Schubert; Jürgen Schrader
Journal:  Circulation       Date:  2008-06-23       Impact factor: 29.690

8.  Abnormal myocardial fluid retention as an early manifestation of ischemic injury.

Authors:  J T Willerson; F Scales; A Mukherjee; M Platt; G H Templeton; G S Fink; L M Buja
Journal:  Am J Pathol       Date:  1977-04       Impact factor: 4.307

9.  Intravenous and intramyocardial injection of apoptotic white blood cell suspensions prevents ventricular remodelling by increasing elastin expression in cardiac scar tissue after myocardial infarction.

Authors:  Michael Lichtenauer; Michael Mildner; Andrea Baumgartner; Matthias Hasun; Gregor Werba; Lucian Beer; Patrick Altmann; Georg Roth; Mariann Gyöngyösi; Bruno Karl Podesser; Hendrik Jan Ankersmit
Journal:  Basic Res Cardiol       Date:  2011-03-17       Impact factor: 17.165

10.  Improved segmented modified Look-Locker inversion recovery T1 mapping sequence in mice.

Authors:  Maryam Nezafat; Isabel T Ramos; Markus Henningsson; Andrea Protti; Tamer Basha; René M Botnar
Journal:  PLoS One       Date:  2017-11-09       Impact factor: 3.240

View more
  8 in total

1.  Dual-Contrast 19F/1H Magnetic Resonance Imaging to Characterize Myocardial Infarct Healing.

Authors:  Gregory M Lanza
Journal:  Circ Cardiovasc Imaging       Date:  2018-11       Impact factor: 7.792

Review 2.  Molecular Imaging in Ischemic Heart Disease.

Authors:  Begoña Lavin Plaza; Iakovos Theodoulou; Imran Rashid; Reza Hajhosseiny; Alkystis Phinikaridou; Rene M Botnar
Journal:  Curr Cardiovasc Imaging Rep       Date:  2019-06-11

Review 3.  Pharmacological Modulation of Cardiac Remodeling after Myocardial Infarction.

Authors:  Wei Zhao; Jia Zhao; Jianhui Rong
Journal:  Oxid Med Cell Longev       Date:  2020-12-30       Impact factor: 6.543

Review 4.  Perfluorocarbons-Based 19F Magnetic Resonance Imaging in Biomedicine.

Authors:  Lina Wu; Fang Liu; Shuang Liu; Xiuan Xu; Zhaoxi Liu; Xilin Sun
Journal:  Int J Nanomedicine       Date:  2020-10-02

Review 5.  Multi-Scale Imaging of Vascular Pathologies in Cardiovascular Disease.

Authors:  Ashish Tiwari; Betsalel Elgrably; Galit Saar; Katrien Vandoorne
Journal:  Front Med (Lausanne)       Date:  2022-01-05

Review 6.  Therapeutic and diagnostic targeting of fibrosis in metabolic, proliferative and viral disorders.

Authors:  Alexandros Marios Sofias; Federica De Lorenzi; Quim Peña; Armin Azadkhah Shalmani; Mihael Vucur; Jiong-Wei Wang; Fabian Kiessling; Yang Shi; Lorena Consolino; Gert Storm; Twan Lammers
Journal:  Adv Drug Deliv Rev       Date:  2021-06-15       Impact factor: 15.470

Review 7.  Is There Preclinical and Clinical Value for 19F MRI in Stem Cell Cardiac Regeneration?

Authors:  Christakis Constantinides
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

8.  Prediction of severity and subtype of fibrosing disease using model informed by inflammation and extracellular matrix gene index.

Authors:  Amin M Cheikhi; Zariel I Johnson; Dana R Julian; Sarah Wheeler; Carol Feghali-Bostwick; Yvette P Conley; James Lyons-Weiler; Cecelia C Yates
Journal:  PLoS One       Date:  2020-10-23       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.